These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6424277)

  • 1. Valproic acid binding to human serum albumin and human plasma: effects of pH variation and buffer composition in equilibrium dialysis.
    Albani F; Riva R; Contin M; Baruzzi A
    Ther Drug Monit; 1984; 6(1):31-3. PubMed ID: 6424277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids.
    Patel IH; Levy RH
    Epilepsia; 1979 Feb; 20(1):85-90. PubMed ID: 369855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
    Wiesner G; Taeger K; Peter K
    Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.
    Riva R; Albani F; Baruzzi A; Galvani I; Perucca E
    Ther Drug Monit; 1982; 4(4):341-52. PubMed ID: 6818733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent.
    Lee WI; Yoon WH; Park JH; Lee JW; Shim CK; Lee MG
    Biopharm Drug Dispos; 1995 Dec; 16(9):775-89. PubMed ID: 8580401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein.
    Ravis WR; Parsons DL; Wang SJ
    J Pharm Pharmacol; 1988 Jul; 40(7):459-63. PubMed ID: 2904983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies of binding of bromosulphthalein sodium by human serum albumin: effects of albumin concentration and buffer composition.
    Thompson JM
    Br J Pharmacol; 1973 Jan; 47(1):133-7. PubMed ID: 4717013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the reactivity of acyl glucuronides--III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans.
    Williams AM; Worrall S; de Jersey J; Dickinson RG
    Biochem Pharmacol; 1992 Feb; 43(4):745-55. PubMed ID: 1540228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum.
    Zimmerman CL; Patel IH; Levy RH; Edwards D; Nelson SD; Hutchinson M
    Epilepsia; 1981 Feb; 22(1):11-7. PubMed ID: 6781885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Displacement effect of valproate on bilirubin-albumin binding in human plasma.
    Yu HY; Shen YZ
    J Formos Med Assoc; 1999 Mar; 98(3):201-4. PubMed ID: 10365540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorochemical emulsion effect on human albumin binding of valproic acid.
    Parsons DL; Ravis WR; Huang HC
    Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):245-8. PubMed ID: 1784838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the modulating effects of temperature, albumin, pH and calcium on the free fractions of phenobarbitone and phenytoin.
    Melten JW; Wittebrood AJ; Wemer J; Faber DB
    J Pharm Pharmacol; 1986 Sep; 38(9):643-6. PubMed ID: 2877062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.
    Semmes RL; Shen DD
    Pharm Res; 1990 May; 7(5):461-7. PubMed ID: 2114617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro protein binding behavior of dipyridamole.
    MacGregor TR; Sardi ED
    J Pharm Sci; 1991 Feb; 80(2):119-20. PubMed ID: 2051312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serum.
    Ponganis KV; Stanski DR
    J Pharm Sci; 1985 Jan; 74(1):57-60. PubMed ID: 3981419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing.
    Rapeport WG; Mendelow AD; French G; MacPherson P; Teasdale E; Agnew E; Thompson GG; Brodie MJ
    Br J Clin Pharmacol; 1983 Oct; 16(4):365-9. PubMed ID: 6414500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.
    Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2000 Oct; 21(7):285-91. PubMed ID: 11512128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate competes with palmitate for binding to serum albumin.
    Vorum H; Andersen S; Brodersen R
    Epilepsia; 1989; 30(3):370-3. PubMed ID: 2498075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.